BEVACIZAB 100 INJECTION contains Bevacizumab, which belongs to
the group of medicines called Antineoplastic agents. It is used in adult
patients with fluoropyrimidine (a chemotherapy medicine) to manage metastatic
cancer in the large bowel (colon or rectum). It is also used with Paclitaxel or
Capecitabine (chemotherapy medicine) to manage metastatic breast cancer in
adult patients.

BEVACIZAB 100 INJECTION is used with a chemotherapy regimen
containing platinum to manage advanced non-small cell lung cancer without
epidermal growth factor receptor (a mutated protein responsible for causing
cancer in a cell) and with Erlotinib (a chemotherapy medicine) to manage
metastatic non-small cell lung cancer with epidermal growth factor
receptor (in cancer cells) in adult patients.

This medicine is indicated for use to manage metastatic kidney
cancer along with interferon (chemotherapy medicine), which is also indicated
for use with carboplatin, gemcitabine, and/or carboplatin and Paclitaxel
(chemotherapy medicine) to manage recurrent advanced epithelial ovarian,
fallopian tube, or primary peritoneal cancer in adult patients.

This medicine is also used to manage persistent, recurrent,
or metastatic cervical cancer with or without Paclitaxel, Cisplatin, or
Paclitaxel and Topotecan in adult patients. BEVACIZAB 100 INJECTION is not
recommended for use in patients allergic to Bevacizumab, Chinese hamster ovary
(CHO) cell products, and/or other recombinant human or humanized antibodies. It
is also not recommended for use in patients who have recently undergone major
operations or surgery.

Before receiving BEVACIZAB 100 INJECTION, inform your doctor if
you are scheduled for an invasive dental management or surgery and/or suffer
from conditions such as inflammation inside the abdomen, uncontrolled high
blood pressure, dental problems, kidney problems, and liver problems (such as
hepatic injury).

BEVACIZAB 100 INJECTION is not recommended for use in pregnant
women or in women planning for pregnancy since it may cause harm to the unborn
baby. It is also not recommended for use by breast-feeding women since it may
interfere with the growth and development of the baby.